Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses.
Sandmair AM, Loimas S, Puranen P, Immonen A, Kossila M, Puranen M, Hurskainen H, Tyynelä K, Turunen M, Vanninen R, Lehtolainen P, Paljärvi L, Johansson R, Vapalahti M, Ylä-Herttuala S. Sandmair AM, et al. Among authors: turunen m. Hum Gene Ther. 2000 Nov 1;11(16):2197-205. doi: 10.1089/104303400750035726. Hum Gene Ther. 2000. PMID: 11084677 Clinical Trial.
Low efficacy of gene therapy for rat BT4C malignant glioma using intra-tumoural transduction with thymidine kinase retrovirus packaging cell injections and ganciclovir treatment.
Sandmair AM, Loimas S, Poptani H, Vainio P, Vanninen R, Turunen M, Tyynelä K, Vapalahti M, Ylä-Herttuala S. Sandmair AM, et al. Among authors: turunen m. Acta Neurochir (Wien). 1999;141(8):867-72; discussion 872-3. doi: 10.1007/s007010050389. Acta Neurochir (Wien). 1999. PMID: 10536724
Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
Sandmair AM, Turunen M, Tyynelä K, Loimas S, Vainio P, Vanninen R, Vapalahti M, Bjerkvig R, Jänne J, Ylä-Herttuala S. Sandmair AM, et al. Among authors: turunen m. Cancer Gene Ther. 2000 Mar;7(3):413-21. doi: 10.1038/sj.cgt.7700132. Cancer Gene Ther. 2000. PMID: 10766347
Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta.
Hiltunen MO, Laitinen M, Turunen MP, Jeltsch M, Hartikainen J, Rissanen TT, Laukkanen J, Niemi M, Kossila M, Häkkinen TP, Kivelä A, Enholm B, Mansukoski H, Turunen AM, Alitalo K, Ylä-Herttuala S. Hiltunen MO, et al. Among authors: turunen mp, turunen am. Circulation. 2000 Oct 31;102(18):2262-8. doi: 10.1161/01.cir.102.18.2262. Circulation. 2000. PMID: 11056103
362 results